Science 361 , 599603 (2018)
Novo Nordisk sues Eli Lilly over claims in weight-loss drug ads Novo called the ads 'maliciously and deceptively false,' while Lilly said it stands by the trial results behind its campaign Novo Nordisk sued Eli Lilly on Tuesday, accusing its rival of misleading consumers by claiming Lillys drugs work better than Novos competing treatments
It works by mimicking the natural GLP-1 hormone, helping control blood sugar, digestion, and appetite
If its only for a short period (e.g., an hour or two), it will likely have minimal impact, but its not ideal
But every citation offered in support of the stack is a study of one compound alone
It is also worth considering the NHS capacity context : the rollout of existing weight management medicines has been constrained by supply shortages and specialist service limitations